ESC 365 - AMPK/PGC1 activation by melatonin attenuates acute doxorubicin cardiotoxicity

ESC Premium Access

AMPK/PGC1 activation by melatonin attenuates acute doxorubicin cardiotoxicity

Session: Poster Session 4 - Arrhythmia and cardio protection pharmacotherapy

Topic: Cardiovascular Pharmacotherapy, Other

Speaker: Doctor D. Liu (Beijing, CN)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Dong Liu

Fuwai Hospital, CAMS and PUMC, Beijing (China)

0 follower

5 more presentations in this session

Proarrhythmic pharmacotherapy and out-of-hospital cardiac arrest - A nationwide Danish study

Speaker: Mr S. Kjeldsen (Gentofte, DK)

Ivabradine is not associated with higher risk of new onset atrial fibrillation among patients with cardiac resynchronization therapy

Speaker: Doctor J. Milner (Coimbra, PT)

Hysteresis between pharmacokinetics and changes in QRS complex duration following flecainide administered via oral inhalation or IV infusion

Speaker: Ms P. Madhavapeddi (Newark, US)

SK channel inhibition did not increase short-term variability of the QT intervals in atrial tachypaced pigs with left ventricular dysfunction in contrast to the positive control dofetilide

Speaker: Miss C. Citerni (Copenhagen, DK)

Beneficial effect of landiolol on adiponectin and high-molecular weight adiponectin level in patients with stable coronary artery disease performed percutaneous coronary intervention

Speaker: Assistant Professor M. Kiyokuni (Yokohama, JP)

Access the full session

Poster Session 4 - Arrhythmia and cardio protection pharmacotherapy

Speakers: Doctor D. Liu, Mr S. Kjeldsen, Doctor J. Milner, Ms P. Madhavapeddi, Miss C. Citerni...

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by